Scott Powers initiated coverage on Rhinomed in Mar 2014 with a price target of 0.08. This was revised lower to 0.06 in Feb 2015 and increased to 0.07. Note he calls this a speculative investment.
Am trying not to get caught too caught up in the upside/downside hype of this one. Good luck to all holders.
- Forums
- ASX - By Stock
- RNO
- morgans
morgans, page-8
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)